SE7701796L - PROCEDURE FOR THE PREPARATION OF DIOXAN DERIVATIVES WITH THERAPEUTIC, SPECIAL ANALGETIC EFFECT - Google Patents

PROCEDURE FOR THE PREPARATION OF DIOXAN DERIVATIVES WITH THERAPEUTIC, SPECIAL ANALGETIC EFFECT

Info

Publication number
SE7701796L
SE7701796L SE7701796A SE7701796A SE7701796L SE 7701796 L SE7701796 L SE 7701796L SE 7701796 A SE7701796 A SE 7701796A SE 7701796 A SE7701796 A SE 7701796A SE 7701796 L SE7701796 L SE 7701796L
Authority
SE
Sweden
Prior art keywords
therapeutic
procedure
special
preparation
analgetic effect
Prior art date
Application number
SE7701796A
Other languages
Swedish (sv)
Other versions
SE428378B (en
Inventor
N R
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE7701796L publication Critical patent/SE7701796L/en
Publication of SE428378B publication Critical patent/SE428378B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7701796A 1972-12-08 1977-02-17 ANALOGY PROCEDURE FOR PREPARING DROXAND DERIVATIVES SE428378B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31322172A 1972-12-08 1972-12-08

Publications (2)

Publication Number Publication Date
SE7701796L true SE7701796L (en) 1977-02-17
SE428378B SE428378B (en) 1983-06-27

Family

ID=23214841

Family Applications (3)

Application Number Title Priority Date Filing Date
SE7316586A SE403377B (en) 1972-12-08 1973-12-07 PROCEDURE FOR DISPOSAL OF DIOXAN DERIVATIVES WITH THERAPEUTIC, SPECIAL ANALGETIC EFFECT
SE7701796A SE428378B (en) 1972-12-08 1977-02-17 ANALOGY PROCEDURE FOR PREPARING DROXAND DERIVATIVES
SE7701795A SE417196B (en) 1972-12-08 1977-02-17 PROPANDIOLS FOR USE AS INTERMEDIATES FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE M-DIOXAN-5-METYLAMINES

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7316586A SE403377B (en) 1972-12-08 1973-12-07 PROCEDURE FOR DISPOSAL OF DIOXAN DERIVATIVES WITH THERAPEUTIC, SPECIAL ANALGETIC EFFECT

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7701795A SE417196B (en) 1972-12-08 1977-02-17 PROPANDIOLS FOR USE AS INTERMEDIATES FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE M-DIOXAN-5-METYLAMINES

Country Status (27)

Country Link
JP (2) JPS5734835B2 (en)
AR (3) AR206306A1 (en)
AT (2) AT332396B (en)
BE (1) BE808340A (en)
BG (4) BG26205A4 (en)
CA (2) CA1014560A (en)
CH (4) CH619219A5 (en)
CS (3) CS222208B2 (en)
CY (1) CY1017A (en)
DD (3) DD115653A5 (en)
DE (1) DE2361340C2 (en)
DK (1) DK134717B (en)
ES (4) ES421291A1 (en)
FR (1) FR2209578B1 (en)
GB (2) GB1455997A (en)
HK (1) HK60479A (en)
HU (2) HU168763B (en)
IE (1) IE40226B1 (en)
IL (1) IL43773A (en)
KE (1) KE2976A (en)
MY (1) MY8000064A (en)
NL (1) NL7316839A (en)
PH (2) PH15197A (en)
SE (3) SE403377B (en)
SU (4) SU578001A3 (en)
YU (3) YU36171B (en)
ZA (1) ZA739207B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9376409B2 (en) * 2012-05-09 2016-06-28 Boehringer Ingelheim International Gmbh Methods for making oxetan-3-ylmethanamines
LV14983B (en) * 2013-10-15 2015-06-20 Olainfarm, A/S Method for producing intermediates of phenibut

Also Published As

Publication number Publication date
BG22386A3 (en) 1977-02-20
SE417196B (en) 1981-03-02
YU318473A (en) 1980-09-25
ES421291A1 (en) 1976-07-01
ES444911A1 (en) 1977-09-01
BE808340A (en) 1974-06-07
CH605903A5 (en) 1978-10-13
YU36020B (en) 1981-11-13
BG21409A3 (en) 1976-05-20
DD109625A5 (en) 1974-11-12
GB1455998A (en) 1976-11-17
FR2209578B1 (en) 1977-09-02
PH14923A (en) 1982-01-29
IE40226L (en) 1974-06-08
AT332396B (en) 1976-09-27
BG21223A3 (en) 1976-03-20
DE2361340A1 (en) 1974-06-12
IE40226B1 (en) 1979-04-11
DK134717B (en) 1977-01-03
GB1455997A (en) 1976-11-17
MY8000064A (en) 1980-12-31
SU578001A3 (en) 1977-10-25
ZA739207B (en) 1975-07-30
CA1014560A (en) 1977-07-26
IL43773A0 (en) 1974-03-14
AT330773B (en) 1976-07-26
ES421290A1 (en) 1976-07-01
CH619219A5 (en) 1980-09-15
SE7701795L (en) 1977-02-17
ES444716A1 (en) 1977-05-16
AU6321773A (en) 1975-06-05
JPS4987681A (en) 1974-08-22
YU35447B (en) 1981-02-28
HU168763B (en) 1976-07-28
YU318573A (en) 1981-06-30
PH15197A (en) 1982-09-17
SU648081A3 (en) 1979-02-15
ATA1026173A (en) 1976-01-15
JPS5742633B2 (en) 1982-09-09
CH630914A5 (en) 1982-07-15
NL7316839A (en) 1974-06-11
FR2209578A1 (en) 1974-07-05
YU109380A (en) 1981-04-30
BG26205A4 (en) 1979-02-15
JPS4987680A (en) 1974-08-22
AR206306A1 (en) 1976-07-15
HK60479A (en) 1979-08-31
KE2976A (en) 1979-07-20
CY1017A (en) 1979-11-23
ATA1026073A (en) 1975-10-15
HU168620B (en) 1976-06-28
CS222208B2 (en) 1983-05-27
CS222209B2 (en) 1983-05-27
SE403377B (en) 1978-08-14
CH614439A5 (en) 1979-11-30
JPS5734835B2 (en) 1982-07-26
IL43773A (en) 1979-05-31
YU36171B (en) 1982-02-25
CA1024150A (en) 1978-01-10
DD115653A5 (en) 1975-10-12
SU587861A3 (en) 1978-01-05
SU663305A3 (en) 1979-05-15
SE428378B (en) 1983-06-27
DE2361340C2 (en) 1983-11-24
DD110864A5 (en) 1975-01-12
CS193480B2 (en) 1979-10-31
AR212012A1 (en) 1978-04-28
DK134717C (en) 1977-05-31
AR212416A1 (en) 1978-07-14

Similar Documents

Publication Publication Date Title
SE387122B (en) PROCEDURE FOR THE PREPARATION OF PYRANO (3,4-B) INDOLE OR TIOPYRANO (3,4-B) INDIVIDUAL DERIVATIVES WITH THERAPEUTIC EFFECT
SE415761B (en) PROCEDURE FOR PREPARING HEXAHYDRO-DIBENSO (B, D) PYRAN-9-ON DERIVATIVES WITH THERAPEUTICAL EFFECT
NO138566C (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2,1,3-BENZOTIADIAZOLE DERIVATIVES
SE395149B (en) PROCEDURE FOR THE PREPARATION OF DIBENSO-TIEPINYLPIPERAZINE DERIVATIVES
SE381047B (en) PROCEDURE FOR PREPARATION OF 3-SUBSTITUTED 1,2-BENSISOXAZOLE DERIVATIVES
SE401676B (en) PROCEDURE FOR THE PREPARATION OF DIBENSOFURAN DERIVATIVES
SE407575B (en) PROCEDURE FOR THE PREPARATION OF 1,3-DIOXAN DERIVATIVES WITH THERAPENTIC EFFECT
SE413244B (en) PROCEDURE FOR THE PREPARATION OF BENZOPYRANES WITH ANALGETIC EFFECT
FI54481C (en) PROCEDURE FOR THE FRAMSTATION OF 5,8-DIHYDRO-2- (1-PIPERAZINYL) -5-OXO (2,3-D) PYRIMIDINE-6-CARBOXYL SYROR WITH THERAPEUTIC NETWORK
SE402102B (en) PROCEDURE FOR THE PREPARATION OF 4-AMINO-N- (1-CYCLOHEXYL-3-PYRROLIDINYL) -N-ALKYL-BENZAMIDE, WITH VALUABLE THERAPEUTIC PROPERTIES
SE397827B (en) PROCEDURE FOR THE PREPARATION OF 1-AMINOMETHYL-2,2-DIPHENYL CYCLOPROPANCARBOXAMIDE DERIVATIVES WITH THERAPEUTIC EFFECT
SE399557B (en) PROCEDURE FOR THE PREPARATION OF TIANTRENE, TIOXANTENE AND PHENOXATIIAN DERIVATIVES
SE392722B (en) PROCEDURE FOR THE PREPARATION OF OXAZOLIDINE DERIVATIVES WITH THERAPEUTIC EFFECT
AR197485A1 (en) PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF ISOINDOLINONE
SE385696B (en) NEW PROCEDURE FOR THE PREPARATION OF N- (1-ETHYL-ALFA-PYRROLIDYLMethyl) -2-METHOXY-5-SULFAMIDOBENSAMIDE WITH THERAPEUTIC PROPERTIES
SE400287B (en) PROCEDURE FOR THE PREPARATION OF FLUORO-SUBSTITUTED THIAXANTENE DERIVATIVES
SE400767B (en) PROCEDURE FOR THE PREPARATION OF ARYLPIPERAZINE DERIVATIVES OF ADENIN
SE7701796L (en) PROCEDURE FOR THE PREPARATION OF DIOXAN DERIVATIVES WITH THERAPEUTIC, SPECIAL ANALGETIC EFFECT
SE394429B (en) PROCEDURE FOR THE PREPARATION OF AMINOPYR ROLE DERIVATIVES WITH THERAPEUTIC EFFECT
SE393980B (en) PROCEDURE FOR THE PREPARATION OF 5- (OCH7-) BENZOYLINDOLIN-2-ONES WITH THERAPEUTIC EFFECT
NO144069C (en) DIFLUORBUTYROPHENON DERIVATIVES USED FOR THE PREPARATION OF THERAPEUTIC ACTIVE BUTYROPHENON DERIVATIVES
SE402914B (en) PROCEDURE FOR THE PREPARATION OF 6-METHYL-2H-PYRANE-2,4 (3H) -DIONE DERIVATIVES WITH HYPOTENSIVE EFFECT
SE394430B (en) PROCEDURE FOR THE PREPARATION OF INDOLYLALKYLAMAMES WITH THERAPEUTIC EFFECT
SE399254B (en) PROCEDURE FOR THE PREPARATION OF CHINAZOLINE DERIVATIVES
SE385897B (en) PROCEDURE FOR THE PREPARATION OF BENSODITIAN PYRONE DERIVATIVES WITH THERAPEUTIC EFFECT